Table 3.
T1 | T2 | |||||||
---|---|---|---|---|---|---|---|---|
HTB Group (n = 17) | Placebo Group (n = 19) | P § | Cohen dc |
HTB Group (n = 17) | Placebo Group (n = 19) | P § | Cohen dc |
|
1HAM-Dtotal score b | 4.35 (6.3) | 1.21 (3.7) | 0.037 * | 0.62 [-0.05-1.29] | 4.82 (7.3) | 3.26 (5.7) | 0.238 | 0.24 [-0.42-0.90] |
2HAM-Dinsomnia b | 0.94 (1.8) | 0.16 (1.0) | 0.053 | 0.55 [-0.11-1.22] | 0.88 (1.7) | 0.58 (1.8) | 0.306 | 0.17 [-0.49-0.83] |
2HAM-Dmood b | 2.35 (3.2) | 0.84 (2.2) | 0.054 | 0.55 [-0.12-1.22] | 2.82 (3.8) | 1.74 (2.5) | 0.156 | 0.33 [-0.33-0.99] |
2HAM-Dsomatic b | 0.59 (1.0) | 0.21 (1.4) | 0.182 | 0.31 [-0.35-0.97] | 0.71 (1.4) | 0.58 (1.4) | 0.390 | 0.09 [-0.56-0.75] |
Abbreviations: HTB hyperthermic baths, HAM-D Hamilton Scale for Depression
aThe intention-to-treat analysis used last-observation-carried-forward
bIndicates differences between HTB and placebo in the change from T0 to T1/T2 to each patient’s own end point for the change in depression rating
cComputed as the difference between the means, M2 – M1, divided by the pooled standard deviation, sigma (σpooled) of both groups. [95% confidence interval]
Data are shown as mean and standard deviation (SD)
§1-tailed t test
1Primary outcome
2Secondary outcome
*P < .05